A citation-based method for searching scientific literature

Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey, Elias Reichel, Gisele Soubrane, Barry Kapik, Kathleen Billman, Frances E Kane, Kenneth Green. Ophthalmology 2012
Times Cited: 304







List of co-cited articles
854 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
609
44

Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Thomas Ciulla, David Boyer, Frank G Holz, Michael Tolentino, Amod Gupta, Lilianne Duarte, Steven Madreperla,[...]. Ophthalmology 2011
247
43


Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
245
30

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
27

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
540
26

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
25

Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries.
Usha Chakravarthy, Simon R Taylor, Frank H Johannes Koch, João Paulo Castro de Sousa, Clare Bailey. Br J Ophthalmol 2019
38
65

Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants.
Peter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, Steven Bloom, David M Brown, Miguel Busquets, Thomas Ciulla, Leonard Feiner, Nelson Sabates, Kathleen Billman,[...]. Ophthalmology 2013
84
29

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
883
23

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.
William Fusi-Rubiano, Chandoshi Mukherjee, Mark Lane, Marie D Tsaloumas, Nicholas Glover, Andrej Kidess, Alastair K Denniston, Helen E Palmer, Avinash Manna, Rupal Morjaria. BMC Ophthalmol 2018
32
65

Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant).
Albert J Augustin, Silvia Bopp, Martin Fechner, Frank Holz, Dirk Sandner, Andrea-M Winkgen, Ramin Khoramnia, Thomas Neuhann, Marcus Warscher, Martin Spitzer,[...]. Eur J Ophthalmol 2020
36
58

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema.
Alexander Eaton, Sean S Koh, Jaime Jimenez, Christopher D Riemann. Ophthalmol Ther 2019
31
67

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J Augustin, Julia Ma, Allen C Ho, Vaishali Patel, Scott M Whitcup,[...]. Am J Ophthalmol 2016
171
20

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
472
19

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
926
17

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
883
17

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Arup Das, Paul G McGuire, Sampathkumar Rangasamy. Ophthalmology 2015
257
17


Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Lee M Jampol, Michele Melia, John A Wells. JAMA Ophthalmol 2018
121
16

Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Peter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, Steven Bloom, David M Brown, Miguel Busquets, Thomas Ciulla, Leonard Feiner, Nelson Sabates, Kathleen Billman,[...]. Ophthalmology 2010
96
16

Pharmacology of Corticosteroids for Diabetic Macular Edema.
Scott M Whitcup, John A Cidlowski, Karl G Csaky, Jayakrishna Ambati. Invest Ophthalmol Vis Sci 2018
49
32

Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
Pedro Romero-Aroca, Marc Baget-Bernaldiz, Alicia Pareja-Rios, Maribel Lopez-Galvez, Raul Navarro-Gil, Raquel Verges. J Diabetes Res 2016
141
15

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
397
14

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Joan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, Michael R Robinson, Scott M Whitcup, Baruch D Kuppermann, Devin Welty. Invest Ophthalmol Vis Sci 2011
348
14

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
578
14

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
303
14

INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.
Yit Yang, Clare Bailey, Anat Loewenstein, Pascale Massin. Retina 2015
64
21

Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Bernardete Pessoa, João Coelho, Nuno Correia, Natália Ferreira, Melo Beirão, Angelina Meireles. Ophthalmic Res 2018
28
46

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
192
13




Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
Careen Lowder, Rubens Belfort, Sue Lightman, C Stephen Foster, Michael R Robinson, Rhett M Schiffman, Xiao-Yan Li, Harry Cui, Scott M Whitcup. Arch Ophthalmol 2011
440
12

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Danni Liu, Roy W Beck, Abdhish R Bhavsar, Neil M Bressler, Lee M Jampol, Michele Melia, Omar S Punjabi, Hani Salehi-Had,[...]. JAMA Ophthalmol 2018
104
12



Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
Paul M Beer, Sophie J Bakri, Ravinder J Singh, Weiguo Liu, George B Peters, Michael Miller. Ophthalmology 2003
395
10

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Julia A Haller, Francesco Bandello, Rubens Belfort, Mark S Blumenkranz, Mark Gillies, Jeffrey Heier, Anat Loewenstein, Young-Hee Yoon, Marie-Louise Jacques, Jenny Jiao,[...]. Ophthalmology 2010
682
10

Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States.
Thomas A Ciulla, Peter Bracha, John Pollack, David F Williams. Ophthalmol Retina 2018
61
16

Role of Inflammation in Diabetic Retinopathy.
Anne Rübsam, Sonia Parikh, Patrice E Fort. Int J Mol Sci 2018
248
10

INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY.
Raj K Maturi, Ayala Pollack, Harvey S Uy, Monica Varano, Andre M V Gomes, Xiao-Yan Li, Harry Cui, Jean Lou, Yehia Hashad, Scott M Whitcup. Retina 2016
66
13

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
465
9

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
José Cunha-Vaz, Paul Ashton, Raymond Iezzi, Peter Campochiaro, Pravin U Dugel, Frank G Holz, Michel Weber, Ronald P Danis, Baruch D Kuppermann, Clare Bailey,[...]. Ophthalmology 2014
88
10




Intraocular pressure monitoring post intravitreal steroids: a systematic review.
Weerawat Kiddee, Graham E Trope, Lisa Sheng, Laura Beltran-Agullo, Michael Smith, M Hermina Strungaru, Jasrajbir Baath, Yvonne M Buys. Surv Ophthalmol 2013
109
9

The Role of Steroids in the Management of Diabetic Macular Edema.
Dinah Zur, Matias Iglicki, Anat Loewenstein. Ophthalmic Res 2019
51
17

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Julia A Haller, Francesco Bandello, Rubens Belfort, Mark S Blumenkranz, Mark Gillies, Jeffrey Heier, Anat Loewenstein, Young Hee Yoon, Jenny Jiao, Xiao-Yan Li,[...]. Ophthalmology 2011
471
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.